Skip to main content
79°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about MNMD
Recent news which mentions MNMD
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows
September 13, 2023
Tickers
MNMD
Tags
Market News
Psychedelics
MNMD
From
Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
Tickers
ATAI
CMPS
CYBN
JAZZ
Tags
Markets
PFE
JNJ
From
Benzinga
MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone
September 12, 2023
Tickers
MNMD
Tags
News
Penny Stocks
MM/120
From
Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
September 11, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
DRUG
Cannabis
Psilocybin program
From
Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Tickers
ATAI
BRAXF
CMPS
CYBN
Tags
NUGL
Legal
PSIL
From
Benzinga
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
August 28, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
Guidance
Financing
Psychedelics Financing
From
Benzinga
Analyst Expectations for Mind Medicine's Future
August 22, 2023
Tickers
MNMD
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
Market News
MYCOF
MNMD
From
Benzinga
MindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational Year
August 14, 2023
Tickers
MNMD
Tags
Markets
Penny Stocks
LSD program
From
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Tickers
AGNPF
ATAI
AWKNF
CMPS
Tags
American Psychedelic Practitioners Association
LSDI
HUGE
From
Benzinga
MindMed's Q2 2023: One Of Biggest Players In The Space Sustains Faith In LSD's Multiple Path Ahead
August 07, 2023
Tickers
MNMD
Tags
News
Guidance
LSD program
From
Benzinga
What 9 Analyst Ratings Have To Say About Mind Medicine
August 04, 2023
Tickers
MNMD
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
August 03, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Penny Stocks
LSDI
HUGE
From
Benzinga
Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
July 28, 2023
Tickers
ATAI
CMPS
DMTTF
DRUG
Tags
Cannabis
DRUG
SILO
From
Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 18, 2023
Tickers
ABOS
ADES
ADN
APLS
Tags
MNMD
ATRO
Market News
From
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Tickers
BETRF
CYBN
DMTTF
DSNKY
Tags
HUGE
Global
Penny Stocks
From
Benzinga
The 3 Best Psychedelic Stocks to Buy Now
June 29, 2023
Tickers
CMPS
GHRS
MNMD
Tags
CMPS
GHRS
MNMD
From
InvestorPlace
The Latest Analyst Ratings for Mind Medicine
June 28, 2023
Tickers
MNMD
Tags
MNMD
Benzinga
BZI/AAR
From
Benzinga
MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld
June 27, 2023
Tickers
MNMD
Tags
Penny Stocks
Annual Shareholder Meeting
Markets
From
Benzinga
TOMS Shoes founder is pledging $100 million for psychedelic research – Here’s why he’s doing it.
June 21, 2023
Tickers
ATAI
CMPS
CYBN
MNMD
Tags
ATAI
MNMD
CMPS
From
MarketWatch
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
June 09, 2023
Tickers
COPHF
MNMD
Tags
Markets
Australia Psychedelics
Global
From
Benzinga
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
June 05, 2023
Tickers
CMPS
MNMD
NUMIF
Tags
News
Markets
Penny Stocks
From
Benzinga
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
May 31, 2023
Tickers
CMPS
CYBN
DMTTF
ENVB
Tags
News
ENVB
PSIL
From
Benzinga
MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens
May 30, 2023
Tickers
MNMD
Tags
MNMD
Benzinga
Institutional Shareholder Services
From
Benzinga
MindMed Calls FDA Experts To Validate LSD Drug Development Strategy
May 25, 2023
Tickers
MNMD
Tags
Markets
Penny Stocks
LSD program
From
Benzinga
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
May 23, 2023
Tickers
ENVB
FLHLF
IXHL
LSDI
Tags
News
Psychedelics Financing
ENVB
From
Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
Tags
Generalized Anxiety Disorder
Psychedelics
Benzinga
From
Benzinga
FCM Holdings Accuse MindMed Braintrust Of 'Pursuing Misguided Clinical Path for MM-120'
May 16, 2023
Tickers
MNMD
Tags
MNMD
Benzinga
contributors
From
Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
May 08, 2023
Tickers
CMND
CMPS
HUGE
IWINF
Tags
Psychedelic/Assisted Therapies
IXHL
Cannabis
From
Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
May 05, 2023
Tickers
MNMD
Tags
financials
Cannabis
Psychedelic/Assisted Therapies
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.